| scholarly article | Q13442814 |
| P2093 | author name string | Li Zhang | |
| Hui Li | |||
| Zhuo Li | |||
| Wei Zhang | |||
| Ying Liu | |||
| Tao Yan | |||
| Ke Li | |||
| Aiqiang Xu | |||
| Jia Wu | |||
| Juan Ma | |||
| Xiaopan Wu | |||
| Xilin Zhu | |||
| P2860 | cites work | Analyzing effects of naturally occurring missense mutations | Q21284966 |
| A simple salting out procedure for extracting DNA from human nucleated cells | Q27861086 | ||
| Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization | Q28115244 | ||
| Cancer gene discovery in hepatocellular carcinoma | Q34002120 | ||
| Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis | Q34189361 | ||
| Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis | Q34586595 | ||
| Estimates for worldwide laboratory animal use in 2005. | Q34801879 | ||
| A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma | Q35085830 | ||
| Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations | Q35831012 | ||
| Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis | Q35882733 | ||
| WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4. | Q36079791 | ||
| Genomics and signaling pathways in hepatocellular carcinoma. | Q36733952 | ||
| Recombinant human epidermal growth factor precursor is a glycosylated membrane protein with biological activity | Q36768926 | ||
| Tackling EGFR signaling with TACE antagonists: a rational target for metalloprotease inhibitors in cancer | Q36956724 | ||
| Mechanisms of hepatocyte growth factor-mediated and epidermal growth factor-mediated signaling in transdifferentiation of rat hepatocytes to biliary epithelium | Q37041709 | ||
| The role of signaling pathways in the development and treatment of hepatocellular carcinoma | Q37773788 | ||
| Metabolism and effects of epidermal growth factor and related growth factors in mammals | Q37977466 | ||
| Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells | Q38327752 | ||
| Expression of betacellulin and epidermal growth factor receptor in hepatocellular carcinoma: implications for angiogenesis | Q38508912 | ||
| Novel EGFR-TK inhibitor EKB-569 inhibits hepatocellular carcinoma cell proliferation by AKT and MAPK pathways | Q39431960 | ||
| Epidermal growth factor induces cytokeratin 19 expression accompanied by increased growth abilities in human hepatocellular carcinoma | Q39653490 | ||
| Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients | Q39785918 | ||
| Liver expression of epidermal growth factor RNA. Rapid increases in immediate-early phase of liver regeneration | Q42476291 | ||
| Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers | Q43413375 | ||
| In silico structural, functional and pathogenicity evaluation of a novel mutation: an overview of HSD3B2 gene mutations | Q45491423 | ||
| Investigating the function of three non-synonymous SNPs in EGFR gene: structural modelling and association with breast cancer. | Q46891260 | ||
| Polymorphisms in EGFR and VEGF contribute to non-small-cell lung cancer survival in a Chinese population. | Q53299875 | ||
| An association between EGF and EGFR gene polymorphisms with gastric cancer in a Chinese Han population. | Q54312858 | ||
| Protein expression, gene amplification, and mutational analysis of EGFR in triple-negative breast cancer. | Q54518974 | ||
| Polymorphisms in the potential functional regions of the TGF-β 1 and TGF-β receptor genes and disease susceptibility in HBV-related hepatocellular carcinoma patients. | Q54533115 | ||
| CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphism | Q57908995 | ||
| Functional single-nucleotide polymorphism of epidermal growth factor is associated with the development of Barrett's esophagus and esophageal adenocarcinoma | Q58376620 | ||
| SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci | Q81459790 | ||
| EGFR mutations, gene amplification, and protein expression and KRAS mutations in primary and metastatic tumors of nonsmall cell lung cancers and their clinical implications: a meta-analysis | Q82096452 | ||
| A functional epidermal growth factor (EGF) polymorphism, EGF serum levels and renal cell carcinoma risk in a Chinese population | Q83131609 | ||
| [Association of genetic polymorphisms of key molecules in JAK/STAT signaling pathway with susceptibility of hepatocellular carcinoma] | Q84104309 | ||
| No association of EGF 5'UTR variant A61G and hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection | Q84870000 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | People's Republic of China | Q148 |
| Hepatitis B virus | Q6844 | ||
| hepatitis B | Q6853 | ||
| hepatocellular carcinoma | Q1148337 | ||
| P304 | page(s) | 595-600 | |
| P577 | publication date | 2013-06-22 | |
| P1433 | published in | Genetic Testing and Molecular Biomarkers | Q15753742 |
| P1476 | title | Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China | |
| P478 | volume | 17 |
| Q34460938 | A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer |
| Q36040133 | Application of a Combined Model with Autoregressive Integrated Moving Average (ARIMA) and Generalized Regression Neural Network (GRNN) in Forecasting Hepatitis Incidence in Heng County, China |
| Q37553969 | Association Study of Polymorphisms of Epidermal Growth Factor and Epidermal Growth Factor Receptor With Benign Prostatic Hyperplasia in a Korean Population. |
| Q92449592 | Association between epidermal growth factor (EGF) and EGF receptor gene polymorphisms and end-stage renal disease and acute renal allograft rejection in a Korean population |
| Q35564471 | Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies |
| Q56513773 | Association of androgen receptor exon 1 CAG repeat length with risk of hepatocellular carcinoma: a case-control study |
| Q33596764 | Different frequency of epidermal growth factor rs76189946 polymorphism genotype in an Iranian colorectal cancer |
| Q42238020 | Haplotype-based case-control study of DNA repair gene XRCC3 and hepatocellular carcinoma risk in a Chinese population |
| Q36335379 | Quantitative assessment of the effect of epidermal growth factor 61A/G polymorphism on the risk of hepatocellular carcinoma |
| Q36581465 | Relationship between HLA-DRB1 allele polymorphisms and familial aggregations of hepatocellular carcinoma |
| Q38188524 | The NQO1 C609T polymorphism and hepatocellular carcinoma risk |
Search more.